|
⚲
|
| Keyboard |
| Hermelin David S
✚
|
|
|---|---|
| CIK # | 0001296276 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001296276] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| K-V Pharmaceutical Co | |
| Hermelin David S |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
K-V Pharmaceutical Co KVA/KVB
Option to Purchase · derivative
|
2013-09-16 | Other | 15,000 | $0.00 | |
|
K-V Pharmaceutical Co KVA/KVB
Class B Common Stock
|
2013-09-16 | Other | 2,136,555 | $0.00 | |
|
K-V Pharmaceutical Co KVA/KVB
Class B Common Stock
|
2013-09-16 | Other | 52,875 | $0.00 | |
|
K-V Pharmaceutical Co KVA/KVB
Class A Common Stock
|
2013-09-16 | Other | 1,343,187 | $0.00 | |
|
K-V Pharmaceutical Co KVA/KVB
Class A Common Stock
|
2013-09-16 | Other | 15,375 | $0.00 | |
|
K-V Pharmaceutical Co KVA/KVB
Option to Purchase · derivative
|
2013-09-16 | Other | 20,000 | $0.00 | |
|
K-V Pharmaceutical Co KVA/KVB
Option to Purchase · derivative
|
2013-09-16 | Other | 20,000 | $0.00 | |
|
K-V Pharmaceutical Co KVA/KVB
Option to Purchase · derivative
|
2013-09-16 | Other | 10,000 | $0.00 | |
|
K-V Pharmaceutical Co KVA
Option to Purchase · derivative
|
2012-05-14 | Grant | 20,000 | $0.00 |